Relationship between endogenous testosterone and cardiovascular risk in early postmenopausal women.

[1]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[2]  P. I. de Bittencourt,et al.  Nitric oxide and fibrinogen in polycystic ovary syndrome: associations with insulin resistance and obesity. , 2007, European journal of obstetrics, gynecology, and reproductive biology.

[3]  P. Spritzer,et al.  Estimation of truncal adiposity using waist circumference or the sum of trunk skinfolds: a pilot study for insulin resistance screening in hirsute patients with or without polycystic ovary syndrome. , 2007, Metabolism: clinical and experimental.

[4]  P. Spritzer,et al.  CAPN10 UCSNP-43, UCSNP-19 and UCSNP-63 polymorphisms and metabolic syndrome in polycystic ovary syndrome , 2007, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[5]  M. Quon,et al.  Reciprocal Relationships Between Insulin Resistance and Endothelial Dysfunction: Molecular and Pathophysiological Mechanisms , 2006, Circulation.

[6]  J. Manson,et al.  Sex hormone-binding globulin and serum testosterone are inversely associated with C-reactive protein levels in postmenopausal women at high risk for cardiovascular disease. , 2006, Annals of epidemiology.

[7]  E. Barrett-Connor,et al.  Cross-sectional association between markers of inflammation and serum sex steroid levels in the postmenopausal estrogen/progestin interventions trial. , 2006, Journal of women's health.

[8]  Barbara Thorand,et al.  Elevated Markers of Endothelial Dysfunction Predict Type 2 Diabetes Mellitus in Middle-Aged Men and Women From the General Population , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[9]  A. Folsom,et al.  Association of Endogenous Hormones with C-reactive Protein, Fibrinogen, and White Blood Count in Post-menopausal Women , 2005, European Journal of Epidemiology.

[10]  R. Little,et al.  Androgens are associated with hemostatic and inflammatory factors among women at the mid-life. , 2005, The Journal of clinical endocrinology and metabolism.

[11]  K. Schenck-Gustafsson,et al.  Does body mass index, smoking, lipoprotein levels, surgically induced menopause, hormone replacement therapy, years since menopause, or age affect hemostasis in postmenopausal women? , 2005, Gender medicine.

[12]  P. Spritzer,et al.  Association between ovarian volume and serum insulin levels in ovulatory patients with idiopathic hirsutism. , 2005, Fertility and sterility.

[13]  Donald Lloyd-Jones,et al.  Sex Hormone–Binding Globulin and the Free Androgen Index Are Related to Cardiovascular Risk Factors in Multiethnic Premenopausal and Perimenopausal Women Enrolled in the Study of Women Across the Nation (SWAN) , 2005, Circulation.

[14]  C. Apovian,et al.  Effect of medical and surgical weight loss on endothelial vasomotor function in obese patients. , 2005, The American journal of cardiology.

[15]  G. Rosano,et al.  Different effect of hormone replacement therapy, DHEAS and tibolone on endothelial function in postmenopausal women with increased cardiovascular risk. , 2002, Maturitas.

[16]  F. Manguso,et al.  Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: results of a 6-month study. , 2005, The Journal of clinical endocrinology and metabolism.

[17]  F. Orio,et al.  The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study. , 2004, The Journal of clinical endocrinology and metabolism.

[18]  L. Ghiadoni,et al.  Mechanisms of endothelial dysfunction: clinical significance and preventive non-pharmacological therapeutic strategies. , 2003, Current pharmaceutical design.

[19]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[20]  P. Ponikowski,et al.  The association of lower testosterone level with coronary artery disease in postmenopausal women. , 2003, International journal of cardiology.

[21]  Katsuhiko Yano,et al.  C-reactive protein and myocardial infarction. , 2002, Journal of clinical epidemiology.

[22]  P. Spritzer,et al.  Association between hyperinsulinemia and endogenous androgen levels in peri- and postmenopausal women. , 2002, Metabolism: clinical and experimental.

[23]  E. Diamanti-Kandarakis,et al.  Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy. , 2001, The Journal of clinical endocrinology and metabolism.

[24]  M. Ghatei,et al.  17β-Estradiol Decreases Endothelin-1 Levels in the Coronary Circulation of Postmenopausal Women With Coronary Artery Disease , 2000 .

[25]  J. Danesh,et al.  Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses , 2000, BMJ : British Medical Journal.

[26]  D A Follmann,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity In Humans , 2022 .

[27]  P. Ridker,et al.  C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. , 2000, The New England journal of medicine.

[28]  D. Singer,et al.  Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study. , 2000, JAMA.

[29]  T. Anderson,et al.  Assessment and treatment of endothelial dysfunction in humans. , 1999, Journal of the American College of Cardiology.

[30]  P. Ridker,et al.  Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. , 1998, Circulation.

[31]  K. Polderman,et al.  Influence of Sex Hormones on Plasma Endothelin Levels , 1993, Annals of Internal Medicine.